This blog is part of our Symposium Blogathon series – where we are counting down to the 33rd International Symposium. Numbers in bold blue type correspond to the code in the abstract book. Click on the number to be redirected to the full abstract.
As a new feature of the Symposium Blogathon, we got in touch with a variety of international researchers who will be presenting at the 33rd International Symposium on ALS/MND. We chatted about what they will be presenting and what they are most looking forward to at the Symposium this year.
Today, we hear from Dr Tatyana Shelkovnikova, from the Sheffield Institute for Translational neuroscience (SITraN). Understanding the biology of what goes wrong in ALS/MND is critical in the hunt for effective treatments. Tatyana is researching a particular molecule, called NEAT1, which is thought to be different in people living with ALS/MND (HCB15).
Listen below to find out more.
Tatyana is also funded by the MND Associations Lady Edith Wolfson Fellowship Programme, as a Senior Non-Clinical Fellow. The Fellowship Programme attracts and develops the careers of outstanding researchers in order to create the future scientific leaders in the field of MND research.
Blog | 24 June 2021 | Research Team
Driving MND research through our Senior Non-Clinical Fellowships
Tatyana’s talks to look out for:
If you have come across this blog through the Symposium website, or a general search please subscribe (see top right-hand corner of page) and you’ll be notified every time we upload a new article.
You can follow our research account on Twitter. We tweet about up to the minute research and will be tweeting throughout the Symposium using the hashtag #alsmndsymp.
Take a look at the schedule of blogs for November as we continue counting down to the 33rd International Symposium on ALS/MND with our Symposium Blogathon.
To listen to talks live, take part in the Q&As and visit the live poster sessions, register for the International Symposium now.